These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8369987)

  • 1. Serum bone Gla protein as a marker of bone turnover in acromegaly.
    Marazuela M; Astigarraga B; Tabuenca MJ; Estrada J; Marín F; Lucas T
    Calcif Tissue Int; 1993 Jun; 52(6):419-21. PubMed ID: 8369987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadal status is an important determinant of bone density in acromegaly.
    Lesse GP; Fraser WD; Farquharson R; Hipkin L; Vora JP
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
    J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of acromegaly with lanreotide: evidence of increased serum parathormone concentration.
    Cappelli C; Gandossi E; Agosti B; Cerudelli B; Cumetti D; Castellano M; Pirola I; De Martino E; Rosei EA
    Endocr J; 2004 Dec; 51(6):517-20. PubMed ID: 15644568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of octreotide on markers of bone metabolism in acromegaly: evidence of increased serum parathormone concentrations.
    Legovini P; De Menis E; Breda F; Billeci D; Carteri A; Pavan P; Conte N
    J Endocrinol Invest; 1997 Sep; 20(8):434-8. PubMed ID: 9364245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metabolism and body composition in Japanese patients with active acromegaly.
    Kaji H; Sugimoto T; Nakaoka D; Okimura Y; Kaji H; Abe H; Chihara K
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):175-81. PubMed ID: 11531923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical assessment of bone formation and resorption in acromegaly.
    Ezzat S; Melmed S; Endres D; Eyre DR; Singer FR
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1452-7. PubMed ID: 8501150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
    Parkinson C; Kassem M; Heickendorff L; Flyvbjerg A; Trainer PJ
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5650-5. PubMed ID: 14671148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between circulating bone-derived hormones lipocalin 2, osteocalcin, and glucose metabolism in acromegaly.
    Zhang Y; Liu M; Chen H; Zhu K; Feng W; Zhu D; Li P
    J Endocrinol Invest; 2020 Sep; 43(9):1309-1316. PubMed ID: 32198716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative changes in bone metabolism and bone mineral density in Japanese patients with acromegaly: a 3-year prospective study.
    Tamada D; Kitamura T; Takahara M; Oshino S; Saitoh Y; Otsuki M; Shimomura I
    Endocr J; 2015; 62(11):1031-6. PubMed ID: 26228662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid decline in bone turnover markers but not bone mineral density in acromegalic patients after transsphenoidal surgery.
    Tamada D; Kitamura T; Onodera T; Tabuchi Y; Fukuhara A; Oshino S; Saitoh Y; Hamasaki T; Otsuki M; Shimomura I
    Endocr J; 2014; 61(3):231-7. PubMed ID: 24304925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment.
    Terzolo M; Piovesan A; Osella G; Pia A; Reimondo G; Pozzi C; Raucci C; Torta M; Paccotti P; Angeli A
    Calcif Tissue Int; 1993 Mar; 52(3):188-91. PubMed ID: 8481830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density and parameters of bone metabolism in patients with acromegaly.
    Kotzmann H; Bernecker P; Hübsch P; Pietschmann P; Woloszczuk W; Svoboda T; Geyer G; Luger A
    J Bone Miner Res; 1993 Apr; 8(4):459-65. PubMed ID: 8475795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly.
    Bolanowski M; Jedrzejuk D; Milewicz A; Arkowska A
    Osteoporos Int; 2002; 13(4):303-8. PubMed ID: 12030545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover in girls during puberty.
    Blumsohn A; Hannon RA; Wrate R; Barton J; al-Dehaimi AW; Colwell A; Eastell R
    Clin Endocrinol (Oxf); 1994 May; 40(5):663-70. PubMed ID: 7516828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies.
    Azinge EC; Bolarin DM
    Niger J Physiol Sci; 2006; 21(1-2):21-5. PubMed ID: 17242729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bone Gla protein: a marker of bone turnover in hyperthyroidism.
    Garrel DR; Delmas PD; Malaval L; Tourniaire J
    J Clin Endocrinol Metab; 1986 May; 62(5):1052-5. PubMed ID: 3485649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.